May 1, 2014 11:57 UTC

Research and Markets: Malaysia Healthcare, Regulatory and Reimbursement Landscape Report 2014

DUBLIN--(BUSINESS WIRE)-- Research and Markets ( has announced the addition of the "CountryFocus: Healthcare, Regulatory and Reimbursement Landscape - Malaysia" report to their offering.

In 2013, Malaysia's population stood at 29.9 million. The past five years have seen steady population growth, which is expected to continue in the future due to a high birth rate, low mortality rate and increased life expectancy. Government initiatives such as Entry Point Projects (EPPs), specifically EPP3, and National Key Economic Areas (NKEAs) to increase investment in the pharmaceutical industry have so far have been successful. The country's pharmaceutical market was estimated at $1.2 billion in 2008 and is projected to reach approximately $3.7 billion by 2020 at a CAGR of 9.5%. The medical device market was worth approximately $585m in 2010, but is growing and currently constitutes approximately 25% of the healthcare expenditure.

These positive trends can primarily be attributed to

  • An increasing elderly population
  • Government initiatives to improve healthcare facilities
  • An increase in medical tourism

Key Topics Covered:

  1. Tables & Figures
  2. Introduction
  3. Overview of Pharmaceutical and Medical Device Markets
  4. Market Access
  5. Country Analysis
  6. Opportunities and Challenges
  7. Appendix

For more information visit


Research and Markets
Laura Wood, Senior Manager.
U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716
Sector: Pharmaceuticals

Source: Research and Markets